Navigation Links
Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results
Date:9/17/2009

SUNNYVALE, Calif., , Sept. 17 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. (Nasdaq: PCYC) today reported financial results for its fourth quarter and fiscal year ended June 30, 2009. During the fourth quarter of fiscal 2009 Pharmacyclics incurred a GAAP net loss of $5.4 million, or $0.20 per share, compared to a net loss of $4.6 million, or $0.18 per share for the fourth quarter of fiscal 2008.

Total non-GAAP net loss for the quarter was $4.2 million in 2009 versus $4.2 million in 2008. The adjustments in the fourth quarter 2009 included share-based compensation expense of $0.4 million; non-cash expenses for interest expense of $0.3 million; and the non recurring French withholding tax payment of $0.6 million. The adjustments in the fourth quarter 2008 included share based compensation of $0.5 million.

Pharmacyclics also reported financial results for the fiscal year ended June 30, 2009. The GAAP net loss reported for the fiscal year ended June 30, 2009 was $23.5 million, or $0.88 per share. This compares to a net loss of $24.3 million, or $0.93 per share, for fiscal year 2008.

Total non-GAAP net loss for the fiscal year was $18.1 million versus $22.0 million for fiscal 2008, approximately 18% below the prior year. The adjustments for fiscal 2009 included a $1.0 million non-recurring payment to Celera Corporation in March 2009 associated with the Servier Collaboration Agreement; share-based compensation expense of $3.3 million, of which $1.8 million related to severance agreements; non-cash interest expense for a loan to an affiliate of Robert W. Duggan of $0.5 million which was recognized for GAAP purposes at higher rates than the actual paid out rate; and the non-recurring French Withholding tax payment of $0.6 million. The adjustments in 2008
'/>"/>

SOURCE Pharmacyclics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. Pharmacyclics Sets Record Date for Rights Offering
2. Pharmacyclics Reports Third Quarter Fiscal 2009 Financial Results
3. Pharmacyclics Announces Dr. Ahmed Hamdy as New Chief Medical Officer
4. Pharmacyclics Receives Nasdaq Notification
5. Pharmacyclics Files Schedule 14D-9 Statement with Securities and Exchange Commission
6. Pharmacyclics Reports Third Quarter 2008 Financial Results
7. Pharmacyclics Announces Conference Call to Discuss Third Quarter 2008 Financial Results
8. Pharmacyclics Announces Conference Call to Discuss Second Quarter 2008 Financial Results
9. Pharmacyclics Receives Non-Approvable Letter from the FDA for Xcytrin for the Treatment of Lung Cancer Brain Metastases
10. J.D. Power and Associates Reports: Among Pharmacy Customers, Satisfaction is Equally as High for the Privately Insured and for Those With Public-Private Insurance
11. Somanetics Reports Financial Results for the Third Quarter of Fiscal 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... As the Mayo Clinic's 2012 published Benicar ... Associates Nationwide Legal Services, A.P.C., comments on these findings ... v. Daiichi Sankyo, Inc., Case No. 3:15-cv-159, in US ... light of a recently filed lawsuit, Ford & Associates ... explore the Mayo Clinic's Benicar case study findings purportedly ...
(Date:3/5/2015)... The global digital PCR (dPCR) and qPCR market is expected to ... to 2019. , The global digital PCR (dPCR) and qPCR market ... to 2019. Although the mature markets such as the U.S., Germany, ... and qPCR market the Asia-Pacific region is expected to grow at ... of the digital PCR (dPCR) and qPCR market is driven by ...
(Date:3/5/2015)... FL (PRWEB) March 05, 2015 ... company focused on the peripheral nerve repair market, reported ... ended December 31, 2014 compared to $2.98 million in ... of its growth strategies. , “Our strong fourth ... our peripheral nerve repair products which is driving increased ...
(Date:3/5/2015)... 2015 Rhode Island Medical Imaging (RIMI) was ... row to support the Providence College (PC) women’s basketball program’s ... purchase of the ‘Think Pink’ uniforms, which were worn during ... opponent DePaul University at Alumni Hall/Mullaney Gymnasium in Providence, R.I. ... of the PC women’s basketball’s ‘Pink Out’ event,” said Dr. ...
(Date:3/5/2015)... 05, 2015 SuperCloset has released a new ... series aims to teach viewers everything they need to know ... Like a SuperPro takes you from seed all the way ... clone, to how to prune Grow Like a SuperPro will ... the whole series for download for a special introductory price ...
Breaking Medicine News(10 mins):Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 2Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 3Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 4Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 2Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 3Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 4Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 2Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 3Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 4Health News:RIMI Teams Up with PC Women’s Basketball in the Fight Against Breast Cancer 2
... campaign against pollution and global warming, whatever George W Bush ... now come out with a report warning that desertification represents ... could set off mass migrations of people fleeing degraded homelands. ... to revise rules on land use to halt overgrazing and ...
... study found that smaller amount of teenagers are drinking on a regular ... for youngsters to get hold of alcohol. Those who never drink at ... latest research. Those who drink on a regular basis - at least ... other hand a third of those who do drink do so to ...
... Thursday to ban all female circumcision, the widely-practised removal of ... of a 12-year-old girl. ,Officially the practice, which ... back to the time of the pharaohs, was banned in ... ,Health Minister Hatem al-Gabali has decided to ban ...
... The World Health Organization (WHO) has said that the risk ... of four hours or more. ,In a research ... that the absolute risk of developing VTE, if seated and ... about 1 in 6000. ,According to the study, ...
... of the surgical students stick themselves with needles and sharp ... be infectious and very often they are unreported. ... reported Martin Makary, M.D., a surgeon at the Johns Hopkins ... New England Journal of Medicine. ,These doctors ...
... a leading healthcare provider in Andhra Pradesh, Thursday announced ... one year to set up new state-of-the-art hospitals ... has just completed 10 years, plans to open new ... Kerala. ,The expansion plans were announced by ...
Cached Medicine News:Health News:Desertification, a Major Threat, Says UN 2Health News:New Study That Small Amount of Teenagers Drinks on a Regular Basis 2Health News:Egypt Outlaws All Female Circumcision 2Health News:Thrombosis Risk in Travel Lasting Over Four Hours is Higher: WHO 2Health News:Surgical Students Fail to Report Needle Stick Injuries 2Health News:Surgical Students Fail to Report Needle Stick Injuries 3
(Date:3/5/2015)... , March 5, 2015  As the ... of regulations, Ethics & Compliance professionals are placing ... a new survey issued today by LRN, the ... education. An overwhelming majority of respondents expressed that ... most important component of E&C training programs (57%), ...
(Date:3/5/2015)... MIAMI , March 5, 2015  Sanomedics, Inc. ... medical technology company focused on developing, manufacturing, and acquiring ... Company,s subsidiary, Thermomedics, Inc., will be exhibiting at booth ... Nurse Practitioners Conference (NAPNAP) taking place on March ... Vegas, NV. The 36 ...
(Date:3/5/2015)... 5, 2015  Relmada Therapeutics, Inc. (OTCQB: RLMD), ... treatment of chronic pain, today announced the appointment ... roles. The panel of experts will provide support ... to advance the company pipeline of novel investigational ... in a range of areas including opioid receptors, ...
Breaking Medicine Technology:Pharmaceutical Ethics & Compliance Professionals Place Company Values Front and Center 2Pharmaceutical Ethics & Compliance Professionals Place Company Values Front and Center 3Sanomedics to Showcase the Caregiver at National Association of Pediatric Nurse Practitioners Conference 2Sanomedics to Showcase the Caregiver at National Association of Pediatric Nurse Practitioners Conference 3Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 2Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 3Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 4
... 10, 2010 The American Council on Exercise (ACE), ... fitness certification, education and training organization in the world, ... will focus on eliminating obesity in America.  As an ... the critical need to regularly engage in physical activity ...
... 2010 Luminex Corporation (Nasdaq: LMNX ... the Stephens Fall Investment Conference to be held ... (Logo:   http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) (Logo:   ... Patrick J. Balthrop, president and chief executive officer, ...
Cached Medicine Technology:American Council on Exercise (ACE) Announces Nationwide Effort to Eliminate Obesity in America 2American Council on Exercise (ACE) Announces Nationwide Effort to Eliminate Obesity in America 3Luminex Corporation to Present at Stephens Fall Investment Conference 2
Ruschelit® PVC. Murphy eye-nasoral. X-ray opaque line. Graduated. Single use. Sterile...
Cuffed pediatric endotracheal tubes, available from 2.5 mm to 4.5 mm inside diameter. Ruschelit® PVC. Magill tip - nasoral. X-ray opaque line. Graduated. Single use. Sterile...
Ruschelit® PVC. Murphy eye-nasoral. Black positioning ring. High volume/low pressure cuff. X-ray opaque line. Graduated. Single use....
Ruschelit® PVC. Siliconized. Stainless steel spiral reinforced. Murphy eye. High volume/low pressure cuff. Connector is permanently fixed into the tube. X-ray opaque. Graduated. Single use. Steri...
Medicine Products: